DXR Form 3: CMO John Jefferies Reports 15,272 Shares and Options
John Jefferies, Chief Medical Officer of DAXOR CORP (DXR), filed an Initial Statement of Beneficial Ownership reporting 15,272 shares of DAXOR common stock owned directly.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
John Jefferies, Chief Medical Officer of DAXOR CORP (DXR), filed an Initial Statement of Beneficial Ownership reporting 15,272 shares of DAXOR common stock owned directly. The filing lists multiple stock options exercisable for a total of ≈18,181 underlying shares across various grant dates and strike prices, with several tranches vesting by 12/01/2025 and one option presently exercisable in full.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Stock Options (right to buy) | -- | -- | -- |
| Holding | Daxor Common Stock | -- | -- | -- |
Footnotes (2)
- F1. This option is presently exercisable in full.
- F2. The stock options will vest in three equal installments on December 1, 2023, December 1, 2024 and December 1, 2025.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Who filed the Form 3 for DAXOR CORP (DXR)?
What stock options are reported on the Form 3 for DXR?
Are any options presently exercisable according to the filing?
When do the vesting tranches for the large option grant occur?
AI-generated analysis. How Rhea-AI works. Not financial advice.
